Home
Browse All Titles
Sign In
Browse All Titles
Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs
About
Table of Contents
Main Index
Image Index
Table Index
Flowchart Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002
◀
*
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
▶
View All
CAA
CAP
capillary leak syndrome (CLS)
CAR
cardiac repolarization (QTc)
carmustine (BCNU)
CAR-T
castration-resistant prostate cancer (CRPC)
Male Hormonal Therapies
Question 10.2
CDA
CDC
CDK inhibitors
antiapoptotic proteins
cell cycle and transcription
CDKs
central nervous system (CNS)
Answer 11.1
Answer 2.2
Anticancer Drug Development: An Introduction
cerebrospinal fluid (CSF)
Anticancer Drug Development: An Introduction
Transplant-Related Agents
cGVHD
checkpoint inhibitors (CPIs)
anti-tumor immunity
immune-related adverse effects
multiple cancers management
Multiple Myeloma as a Paradigm for Multi-Targeted Intervention
checkpoint kinase 1 (CHK1)
chimeric antigen receptor (CAR)
Immunotherapeutics Including Vaccines, Bispecifics, CAR-T, and Checkpoint Inhibitors
Multiple Myeloma as a Paradigm for Multi-Targeted Intervention
T-cell therapy
CHK1
cHL
chloroacetaldehyde (CAA)
chronic graft-versus-host disease (cGVHD)
chronic lymphocytic leukemia (CLL)
Antimetabolites: Hydroxyurea, Pyrimidine and Purine Analogs, and L-Asparaginase
DNA Repair, Apoptotic Pathways, CDK Inhibitors
Question 3.1
Targeted Therapies (Small Molecules)
chronic myeloid leukemia (CML)
CJD
cladribine, cytarabine, and filgrastim with mitoxantrone (CLAG-M)
Answer 3.2
Question 3.7
CLAG-M
classic Hodgkin's lymphoma (cHL)
Clinical trials
CLL
Refresh
first
prev
1
2
3
30
select
next
last
Displaying items 1 - 30 of 67